Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06964100 · ClinicalTrials.gov registry record
Exploring the Relationship Between Heart Rate Variability (HRV), Training Load, and Endurance Performance
A clinical trial of Heart Rate Variability, sponsored by PepsiCo Global R&D.
- Recruiting
- Registry status
- 200
- Enrollment target
- 1
- Study location
NCT06964100: Recruiting study of Heart Rate Variability, sponsored by PepsiCo Global R&D.
NCT06964100 is a study of Heart Rate Variability that is actively recruiting participants, run by PepsiCo Global R&D. The registered enrollment target is 200 participants, above the 115-participant average among 5 other Heart Rate Variability trials with a reported enrollment target (74% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06964100, a study of Heart Rate Variability, is actively recruiting participants, sponsored by PepsiCo Global R&D.
- RECRUITING
- Registry status
- 200 participants
- Enrollment target
- 1
- Study location
Study Summary
The ability of smart phones, aided by wearable devices (e.g. smart watches), to collect a variety of data, including physical activity, heart rate, and other exercise metrics, may provide a unique opportunity to understand real-world variability. The primary objective of this study is to test user engagement, app functionality, and feasibility of the newly developed Gatorade Sports Science Institute (GSSI) Labs App to conduct Real-World research studies. The secondary purpose of this study is to determine if Training Intensity (%Heart Rate maximum) in minutes during low heart rate variability (HRV) periods (below HRV baseline consecutive days) will have a negative relationship with post-study 5K (5 kilometer) running times as measured by their activity tracker, which could lead to personalized training recommendations using HRV. This study is conducted remotely, there are no in-person visits.
Primary Outcome
Percent (%) who complete enrollment, informed consent form (ICF), demographics, sync biometrics, complete journal entries, 5 kilometer (5K) performance assessment, and complete study
Conditions Studied
Study Locations (1)
Illinois
- Remote study, no physical site. Managed by Gatorade Sports Science Institute. Do not contact investigators to enroll. Recruitment is handled by an independent agency. - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2025-04-04 |
| Est. Completion | 2025-12-30 |
What NCT06964100 shows while recruiting
NCT06964100 is an observational study that tracks outcomes without assigning an intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, above the 115-participant average among 5 other Heart Rate Variability trials with a reported enrollment target (74% higher).
The record links to 1 condition, with Heart Rate Variability appearing as the primary indexed condition, and to 0 interventions.
NCT06964100 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT06964100 about?
NCT06964100 is a clinical study titled "Exploring the Relationship Between Heart Rate Variability (HRV), Training Load, and Endurance Performance". The ability of smart phones, aided by wearable devices (e.g. smart watches), to collect a variety of data, including physical activity, heart rate, and other exercise metrics, may provide a unique opportunity to understand real-world variability. The primary objective of this study is to test user e...
What is the current status of trial NCT06964100?
This trial is currently recruiting. The enrollment target is 200 participants. The study started on 2025-04-04. Estimated completion is 2025-12-30.
What conditions does trial NCT06964100 study?
This clinical trial studies the following conditions: Heart Rate Variability.
Who is sponsoring clinical trial NCT06964100?
This trial is sponsored by PepsiCo Global R&D, which has 47 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06964100 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Heart Rate Variability
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Novel Mental Health Therapies to Improve Military Readiness
RECRUITING · NA
-
Exploring the Relationship Between Heart Rate Variability (HRV), Training Load, and Exercise Performance
RECRUITING · NA
-
Eastern Principles Acceptance and Commitment Therapy For Injury Prevention Among Nurses and Nursing Aides
RECRUITING · NA
-
The Heart of the Community Study
COMPLETED · NA
-
Impact of Intra-Shift Napping on EMS Cardiovascular Health
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI